{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:19:10Z","timestamp":1787761150493,"version":"build-2784847793"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031585","name":"Takeda Development Center Americas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031585","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Vessels, Thrombosis & Hemostasis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bvth.2026.100179","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T22:15:22Z","timestamp":1781907322000},"page":"100179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A rapid ADAMTS13 activity assay using a portable readout device"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8673-1065","authenticated-orcid":false,"given":"Theodora J.","family":"Steeghs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerissa M. M.","family":"Coolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8499-4409","authenticated-orcid":false,"given":"Elena","family":"Krivosheeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P. L.","family":"Kuijpers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4451-4463","authenticated-orcid":false,"given":"Jona","family":"Merx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9141-8784","authenticated-orcid":false,"given":"Thomas J.","family":"Boltje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1801-2072","authenticated-orcid":false,"given":"Nicole M. A.","family":"Blijlevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2423-2829","authenticated-orcid":false,"given":"Saskia E. M.","family":"Schols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis","family":"van 't Veer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7101-8775","authenticated-orcid":false,"given":"Waander L.","family":"van Heerde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bvth.2026.100179_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.20","article-title":"Thrombotic thrombocytopenic purpura","volume":"3","author":"Kremer Hovinga","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"10.1016\/j.bvth.2026.100179_bib2","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2141.2008.07276.x","article-title":"Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features","volume":"142","author":"Scully","year":"2008","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.bvth.2026.100179_bib3","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1182\/blood-2002-02-0344","article-title":"Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura","volume":"100","author":"Bianchi","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bvth.2026.100179_bib4","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3390\/jcm10030536","article-title":"Thrombotic thrombocytopenic purpura: pathophysiology, diagnosis, and management","volume":"10","author":"Sukumar","year":"2021","journal-title":"J Clin Med"},{"issue":"21","key":"10.1016\/j.bvth.2026.100179_bib5","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly","year":"2017","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bvth.2026.100179_bib6","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1111\/jth.15873","article-title":"Mechanisms of ADAMTS13 regulation","volume":"20","author":"DeYoung","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"11","key":"10.1016\/j.bvth.2026.100179_bib7","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1016\/j.jtha.2025.06.002","article-title":"2025 focused update of the 2020 ISTH guidelines for management of thrombotic thrombocytopenic purpura","volume":"23","author":"Zheng","year":"2025","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.bvth.2026.100179_bib8","first-page":"127","article-title":"Advantages and limits of ADAMTS13 testing in thrombotic thrombocytopenic purpura","volume":"6","author":"Franchini","year":"2008","journal-title":"Blood Transfus"},{"issue":"4","key":"10.1016\/j.bvth.2026.100179_bib9","first-page":"345","article-title":"Validation of PLASMIC score in a cohort of patients with suspected thrombotic microangiopathy in an academic medical centre","volume":"21","author":"Tufano","year":"2023","journal-title":"Blood Transfus"},{"issue":"4","key":"10.1016\/j.bvth.2026.100179_bib10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa1806311","article-title":"Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura","volume":"380","author":"Scully","year":"2019","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.bvth.2026.100179_bib11","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1056\/NEJMoa2314793","article-title":"Recombinant ADAMTS13 in congenital thrombotic thrombocytopenic purpura","volume":"390","author":"Scully","year":"2024","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.bvth.2026.100179_bib12","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1056\/NEJMoa2402567","article-title":"Recombinant ADAMTS13 for immune thrombotic thrombocytopenic purpura","volume":"390","author":"Bendapudi","year":"2024","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.bvth.2026.100179_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12711","article-title":"Economic impact of a rapid, on-demand ADAMTS-13 activity assay for the diagnosis of thrombotic thrombocytopenic purpura","volume":"6","author":"White","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"9","key":"10.1016\/j.bvth.2026.100179_bib14","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1182\/bloodadvances.2024012608","article-title":"Cost-effectiveness of rapid vs in-house vs send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpura","volume":"8","author":"Allen","year":"2024","journal-title":"Blood Adv"},{"issue":"14","key":"10.1016\/j.bvth.2026.100179_bib15","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1182\/blood.2020009150","article-title":"Redefining outcomes in immune TTP: an international working group consensus report","volume":"137","author":"Cuker","year":"2021","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bvth.2026.100179_bib16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/ijlh.13295","article-title":"International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of ADAMTS13","volume":"42","author":"Mackie","year":"2020","journal-title":"Int J Lab Hematol"},{"issue":"3","key":"10.1016\/j.bvth.2026.100179_bib17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1538-7836.2008.03250.x","article-title":"VH1-69 germline encoded antibodies directed towards ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura","volume":"7","author":"Pos","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"8016","key":"10.1016\/j.bvth.2026.100179_bib18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bvth.2026.100179_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2025.117469","article-title":"Novel microfluidic device for factor VIII quantification by chemiluminescence in hemophilia A patients","volume":"282","author":"Steeghs","year":"2025","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/j.bvth.2026.100179_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-med-061813-013241","article-title":"ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura","volume":"66","author":"Zheng","year":"2015","journal-title":"Annu Rev Med"},{"issue":"10","key":"10.1016\/j.bvth.2026.100179_bib21","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1111\/jth.15006","article-title":"ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"suppl 1","key":"10.1016\/j.bvth.2026.100179_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/ijlh.13954","article-title":"Diagnosis and treatment of thrombotic microangiopathy","volume":"44","author":"Thompson","year":"2022","journal-title":"Int J Lab Hematol"},{"issue":"6","key":"10.1016\/j.bvth.2026.100179_bib23","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/bjh.15219","article-title":"The utility of a fast turnaround ADAMTS13 activity in the diagnosis and exclusion of thrombotic thrombocytopenic purpura","volume":"184","author":"Thomas","year":"2019","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.bvth.2026.100179_bib24","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/ajh.26241","article-title":"Laboratory testing for ADAMTS13: Utility for TTP diagnosis\/exclusion and beyond","volume":"96","author":"Favaloro","year":"2021","journal-title":"Am J Hematol"},{"issue":"suppl 1","key":"10.1016\/j.bvth.2026.100179_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/ijlh.13557","article-title":"ADAMTS13 testing update: focus on laboratory aspects of difficult thrombotic thrombocytopenic purpura diagnoses and effects of new therapies","volume":"43","author":"Smock","year":"2021","journal-title":"Int J Lab Hematol"},{"issue":"2","key":"10.1016\/j.bvth.2026.100179_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100108","article-title":"ADAMTS13 activity testing: evaluation of commercial platforms for diagnosis and monitoring of thrombotic thrombocytopenic purpura","volume":"7","author":"Singh","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"2","key":"10.1016\/j.bvth.2026.100179_bib27","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1182\/blood-2003-08-2861","article-title":"VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13","volume":"103","author":"Kokame","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bvth.2026.100179_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","article-title":"FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay","volume":"129","author":"Kokame","year":"2005","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.bvth.2026.100179_bib29","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1537-2995.2006.00914.x","article-title":"Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity","volume":"46","author":"Kato","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.bvth.2026.100179_bib30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/978-1-0716-3175-1_32","article-title":"Automated and rapid ADAMTS13 testing using chemiluminescence: utility for identification or exclusion of TTP and beyond","volume":"2663","author":"Favaloro","year":"2023","journal-title":"Methods Mol Biol"},{"issue":"7","key":"10.1016\/j.bvth.2026.100179_bib31","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.jtha.2025.02.038","article-title":"Real-world evaluation of a novel automated method for measuring ADAMTS-13 activity using the Ceveron s100 analyzer","volume":"23","author":"Joly","year":"2025","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.bvth.2026.100179_bib32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1182\/blood.2025028416","article-title":"Rapid ADAMTS13 activity assays for thrombotic thrombocytopenic purpura: a systematic review and meta-analysis","volume":"146","author":"Deshpande","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.bvth.2026.100179_bib33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2147\/JBM.S464365","article-title":"A systematic review of the epidemiology and disease burden of congenital and immune-mediated thrombotic thrombocytopenic Purpura","volume":"15","author":"Du","year":"2024","journal-title":"J Blood Med"},{"issue":"1","key":"10.1016\/j.bvth.2026.100179_bib34","article-title":"Emerging microfluidic plasma separation technologies for point-of-care diagnostics: moving beyond conventional centrifugation","volume":"16","author":"Tarim","year":"2025","journal-title":"Biosensors (Basel)"},{"issue":"11","key":"10.1016\/j.bvth.2026.100179_bib35","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1111\/trf.14230","article-title":"ADAMTS13 test and\/or PLASMIC clinical score in management of acquired thrombotic thrombocytopenic purpura: a cost-effective analysis","volume":"57","author":"Kim","year":"2017","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.bvth.2026.100179_bib36","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/vox.12912","article-title":"Potential impact of a delayed ADAMTS13 result in the treatment of thrombotic microangiopathy: an economic analysis","volume":"115","author":"Kim","year":"2020","journal-title":"Vox Sang"},{"issue":"2","key":"10.1016\/j.bvth.2026.100179_bib37","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/trf.13359","article-title":"Effect of ADAMTS13 activity turnaround time on plasma utilization for suspected thrombotic thrombocytopenic purpura","volume":"56","author":"Connell","year":"2016","journal-title":"Transfusion"},{"issue":"suppl 1","key":"10.1016\/j.bvth.2026.100179_bib38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1182\/blood-2020-140135","article-title":"Rapid turnaround ADAMTS13 testing is likely to improve diagnosis of thrombotic thrombocytopenic purpura and avoid unnecessary plasma exchange [abstract]","volume":"136","author":"McGinnis","year":"2020","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.bvth.2026.100179_bib39","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1182\/blood.2024026390","article-title":"Impact of new medications on the treatment of immune TTP","volume":"145","author":"Scully","year":"2025","journal-title":"Blood"}],"container-title":["Blood Vessels, Thrombosis & Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:25:04Z","timestamp":1787757904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950327226000446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2950327226000446"],"URL":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100179","relation":{},"ISSN":["2950-3272"],"issn-type":[{"value":"2950-3272","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A rapid ADAMTS13 activity assay using a portable readout device","name":"articletitle","label":"Article Title"},{"value":"Blood Vessels, Thrombosis & Hemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100179"}}